NCT05586516 2025-03-20A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic CanceriOncturaPhase 1/2 Active not recruiting24 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled